Xiaoqian Lu

机构：Jimei University, Anhui Medical University, Wuhan University, Zhongshan People's Hospital, Zhongshan Hospital, Anhui Provincial Children's Hospital

发表论文 75 篇 · 总被引 464 次 · h-index 10

代表论文

• Epigenetic programming mediates abnormal gut microbiota and disease susceptibility in offspring with prenatal dexamethasone exposure (2024 · Cell Reports Medicine · 被引 14)
• FURVENT: Phase 3 trial of furmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004). (2024 · Journal of Clinical Oncology · 被引 10)
• FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004) (2024 · Lung Cancer · 被引 7)
• Massive hemothorax induced by pulmonary arteriovenous malformation rupture: a case report and literature review (2024 · Journal of Cardiothoracic Surgery · 被引 6)
• Serpina3c protects against metabolic dysfunction-associated steatotic liver disease in offspring induced by prenatal prednisone exposure (2026 · Signal Transduction and Targeted Therapy · 被引 5)
• CT radiomics from intratumor and peritumor regions for predicting poorly differentiated invasive nonmucinous pulmonary adenocarcinoma (2025 · Scientific Reports · 被引 5)